CN202854143U - Detection card for varicella IgG (Intravenous Gamma Globulin) antibody - Google Patents
Detection card for varicella IgG (Intravenous Gamma Globulin) antibody Download PDFInfo
- Publication number
- CN202854143U CN202854143U CN 201220591909 CN201220591909U CN202854143U CN 202854143 U CN202854143 U CN 202854143U CN 201220591909 CN201220591909 CN 201220591909 CN 201220591909 U CN201220591909 U CN 201220591909U CN 202854143 U CN202854143 U CN 202854143U
- Authority
- CN
- China
- Prior art keywords
- varicella
- control line
- igg antibody
- nitrocellulose filter
- fiberglass packing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a detection card for a varicella IgG (Intravenous Gamma Globulin) antibody. The detection card comprises a liner (7), a sample pad (1), a glass fiber pad (2), a nitrocellulose film (5) and an adsorption pad (6), wherein the sample pad (1), the glass fiber pad (2), the nitrocellulosefilm (5) and the adsorption pad (6) are sequentially connected in a horizontal direction and fixed onto the liner (7); coloured latex particles with marks are sprayed on the glass fiber pad (2); and a test line (3) formed by varicella virus antigens, and a control line (4) parallel to the test line are placed on the nitrocellulose film (5). By adopting the detection card for the varicella IgG antibody, whether the IgG antibody for resisting varicella-zoster virus is generated in a human body vaccinated with varicella vaccine can be quickly detected, the operation in detection is simple and convenient, and the production cost is low.
Description
Technical field
The utility model belongs to technical field of immunoassay, particularly a kind of varicella IgG antibody test card for whether producing the IgG antibody of anti-varicellazoster virus in the human body behind the fast detecting inoculation chicken pox vaccine.
Background technology
Adopt euzymelinked immunosorbent assay (ELISA) (commercial reagent box for detection of whether producing anti-varicellazoster virus IgG antibody in the human body behind the inoculation chicken pox vaccine at present more, varicellazoster virus IgG TPPA kit (euzymelinked immunosorbent assay (ELISA))), the method is after the human serum with the immunity inoculation chicken pox vaccine dilutes, be added in the microwell plate of coated varicellazoster virus antigen, 37 ℃ hatch 1 hour after, washing for several times, add anti-human IgG enzyme labeling thing, again through washing, add the substrate colour developing, the size of OD value is judged the IgG antibody that whether contains anti-varicellazoster virus in the human serum per sample.
The technical matters that the method exists: 1, complex operation: test procedure is more.Serum to be checked or blood plasma need dilute, and the first two reactions steps need be carried out the several washing, and last microplate reader reads the OD value; 2, length consuming time: three steps (adding sample, enzyme mark thing, substrate) all need 37 ℃ and hatch in the process of the test, add wash time, and whole test needs 3 hours consuming time.
The utility model content
Technical problem to be solved in the utility model provides a kind of varicella IgG antibody test card, and whether its can fast detecting produces the IgG antibody of anti-varicellazoster virus behind inoculation chicken pox vaccine in the human body, detects easy and simple to handlely, and production cost is low.
The utility model solves the problems of the technologies described above the technical scheme that adopts: a kind of varicella IgG antibody test card comprises liner, sample pad, fiberglass packing, nitrocellulose filter and absorption pad; Described sample pad, fiberglass packing, nitrocellulose filter and absorption pad join with the horizontal direction order and are fixed on the described liner; And be coated with the colored latex particle of tape label on the described fiberglass packing; Be provided with the test wire of varicella virus antigen formation and the control line parallel with described test wire on the described nitrocellulose filter.
Further, described test wire is between sample pad and control line.Described test wire is that the varicella virus antigen with purifying is fixed on the described nitrocellulose filter and forms.
Further, described liner main body is rigid plastic or hard paper.
In the technique scheme, described sample pad and absorption pad all adopt the material with water absorbing properties to be prepared from, and can be commercially available filter paper and make, and the preferred stronger qualitative filter paper of water absorbing properties is beneficial to detection like this, increases detection speed.Described nitrocellulose filter is commercially available nitrocellulose filter, and nitrocellulose filter claims again the NC film, is used as the supporting body of C/T line in colloid gold test paper, also is immunoreactive nidus simultaneously.Nitrocellulose filter model 135s, 170s or the definition of 180s(take second as unit adopted: every 4cm film, what seconds the chromatography time of water is).Fiberglass packing is a kind of of fiberglass products.Glass fibre is a kind of Inorganic Non-metallic Materials of excellent performance.English former Glassfiber by name, composition is silicon dioxide, aluminium oxide, calcium oxide, boron oxide, magnesium oxide, sodium oxide molybdena etc.It is through high temperature melting, wire drawing, doff, the technique such as weave cotton cloth take glass bead or discarded glass as raw material, form at last various product, the glass fiber single filament diameter is from several microns to twenties microns, the 1/20-1/50 that is equivalent to a hairline, every bundle fiber precursor all is comprised of hundreds of even thousands of monofilament, usually as reinforcing material, electrically insulating material and heat-insulating material in the multiple material, circuit substrate etc. are widely used in the national economy every field.
Evenly be coated with the colored latex particle of tape label on the described fiberglass packing, colored latex particle generally adopts red latex particle, and colour developing obviously like this; The method of the enterprising row labels of latex particle is the routine techniques means in this area, and the inventor does not do at this and gives unnecessary details.The mark of colored latex particle band can be combined by the IgG antibody in human serum, is antigen on the test wire.
As preferably, described fiberglass packing is the fiberglass packing of the colored latex particle that is coated with band staphylococcal protein A (Staphylococal Protein A, SPA) mark.Staphylococcal protein A is a kind of protein that separates from the aureus cell wall.Since SPA can with the Fc end combination of the IgG of people, mouse, rabbit etc., become a kind of extremely useful instrument on the immunology.Described control line is that SPA is fixed on the control line that forms on the nitrocellulose filter.Described control line is corresponding with label.
As preferably, described fiberglass packing is the fiberglass packing that is coated with the colored latex particle of mouse-anti human IgG labeling of monoclonal antibody.Mouse-anti human IgG monoclonal antibody is a kind of preferably label.Described control line is that sheep anti-mouse igg antibody is fixed on the control line that forms on the nitrocellulose filter.Sheep anti-mouse igg antibody claims again the sheep anti-mouse igg polyclonal antibody.Sheep anti-mouse igg (immunoglobulin (Ig)) polyclonal antibody in the quick antibody diagnostic products of colloidal gold method on nitrocellulose filter, with the monoclonal antibody generation specific immune response of colloid gold label and show certain color, form control line and carry out immunodiagnosis.
Detection principle of the present utility model is: detection of the present utility model is to finish under the promotion of chromatography effect.After blood serum sample is added on the sample pad, arrive fiberglass packing by the chromatography effect, IgG antibody in the blood serum sample is combined with the colored latex particle of mark and is formed in conjunction with particle, then further to nitrocellulose filter, under the chromatography effect of nitrocellulose filter, move forward in conjunction with particle, when containing the antibody of anti-varicellazoster virus in the serum (should produce this antibody after inoculating chicken pox vaccine), be combined with corresponding test wire, the color lines that present particle, unconjugated particle can continue to move forward, and is combined the color lines that present particle with control line, namely shows two color lines of test wire and control line; When not containing the antibody of anti-varicellazoster virus in the serum; the antigen of particle and corresponding test wire can't in conjunction with, test wire does not develop the color, for the particle of combination can continue to move forward; be combined the color lines that present particle with control line, namely only show color line of control line.
Because rete is analysed speed, the colored latex particle of tape label is removable complete nitrocellulose filter bar in a few minutes, at once can sentence read result, all develop the color such as test wire and control line, and serum antibody is positive; Only have line colour developing of control line, serum antibody is negative.
In sum, the beneficial effects of the utility model are:
(1) anti-varicellazoster virus IgG antibody is the species specificity protection antibody that produces in the human body behind the inoculation chicken pox vaccine.When only having this species specificity protection antibody in the human body, could when human body touches varicellazoster virus, kill the virus neutralization not infected.The utility model varicella IgG antibody test card has not only solved existing for detection of whether producing the euzymelinked immunosorbent assay (ELISA) complex operation of the IgG antibody of anti-varicellazoster virus, the defective of length consuming time in the human body behind the inoculation chicken pox vaccine; Simultaneously it can detect after people's vaccine inoculation whether produced this species specificity protection antibody in the body quickly and efficiently.
When (2) the utility model uses, only need sample to be checked with physiological saline 1:1 dilution, directly be added on the utility model sample pad and get final product, operate very easy; Sample is added on the utility model sample pad, and naked eyes were the Observable testing result in 10 minutes, judges about 15 minutes consuming time of whole detection, weak point consuming time.
Description of drawings
Fig. 1 is the vertical view of embodiment 1;
Fig. 2 is the cut-open view of embodiment 1.
The corresponding component names of mark is among the figure: 1-sample pad, 2-fiberglass packing, 3-test wire, 4-control line, 5-nitrocellulose filter, 6-absorption pad, 7-liner.
Embodiment
Below by specific embodiment, and by reference to the accompanying drawings, the technical solution of the utility model is described in further detail.
As illustrated in fig. 1 and 2, a kind of varicella IgG antibody test card, comprise liner 7, the main body of liner 7 is plastic mattress, the surface of plastic mattress is coated with adhesive sticker, along continuous straight runs fixedly has the sample pad 1(filter paper of water absorbing properties successively on the described liner 7, Shanghai gold mark Bioisystech Co., Ltd), fiberglass packing 2(Ahlstrom 8964 glasses, the outstanding Bioisystech Co., Ltd in Shanghai, model JY-J101), nitrocellulose filter 5(nitrocellulose filter, Millipore company, model 135s) and have the absorption pad 6(filter paper of water absorbing properties, Shanghai gold mark Bioisystech Co., Ltd).
Described fiberglass packing 2 is for evenly being coated with red latex particle (the red polystyrene latex particle with the SPA mark, the outstanding Bioisystech Co., Ltd in Shanghai, model PSR030N) method that fiberglass packing, latex particle carry out mark is techniques well known, and therefore not to repeat here.
The purifying varicellazoster virus antigen that described test wire 3 is deactivations (commercially available, buy from Shenzhen phenanthrene roc Biological Co., Ltd. article No.: BA-VZ-02) be fixed on formation on the nitrocellulose filter 5.
Described control line 4 is that SPA(is commercially available, Zhengzhou hundred basic Bioisystech Co., Ltd) be fixed on the nitrocellulose filter 5 and form.Purifying varicellazoster virus antigen, SPA fixing means are techniques well known, and therefore not to repeat here.
In the utility model, described sample pad 1, fiberglass packing 2, nitrocellulose filter 5 and absorption pad 6 join with the horizontal direction order.Particularly, the mode that described sample pad 1, fiberglass packing 2, nitrocellulose filter 5 and absorption pad 6 orders are joined is partly overlapping, that is: the tail end of sample pad 1 is overlapped on the fiberglass packing 2, the tail end of fiberglass packing 2 is overlapped on the head end of nitrocellulose filter 5, and the head end of absorption pad 6 is overlapped on the tail end of nitrocellulose filter 5.
Present embodiment is substantially the same manner as Example 1, and its different piece only is: described liner 7 main bodys are hard paper.Described fiberglass packing 2 is for evenly being coated with the fiberglass packing with the colored latex particle of mouse-anti human IgG labeling of monoclonal antibody, and described control line 4 forms for sheep anti-mouse igg antibody is fixed on the nitrocellulose filter 5.
Present embodiment is substantially the same manner as Example 1, and its different piece only is: the mode that the order that described sample pad 1, fiberglass packing 2, nitrocellulose filter 5 are connected with absorption pad is joined is that head and the tail connect and do not have overlapping.
Present embodiment is substantially the same manner as Example 3, its different piece only is: described fiberglass packing 2 is for being coated with the fiberglass packing with the colored latex particle of mouse-anti human IgG labeling of monoclonal antibody, and described control line 4 forms for sheep anti-mouse igg antibody is fixed on the nitrocellulose filter 5.
When the utility model uses, only need sample to be checked with physiological saline 1:1 dilution, directly be added on the sample pad of the present utility model and get final product, operate very easy; Sample is added on the utility model sample pad, and naked eyes were the Observable testing result in 10 minutes, judges, all develops the color such as test wire 3 and control line 4, and serum antibody is positive; Only have 4 one line colour developings of control line, serum antibody is negative.About 15 minutes consuming time of whole detection, weak point consuming time.
Above-described embodiment is a kind of better embodiment of the present utility model, is not to any pro forma restriction of the utility model, also has other variant and remodeling under the prerequisite that is no more than the technical scheme that claim puts down in writing.
Claims (5)
1. a varicella IgG antibody test card comprises liner (7), it is characterized in that, also comprises sample pad (1), fiberglass packing (2), nitrocellulose filter (5) and absorption pad (6); Described sample pad (1), fiberglass packing (2), nitrocellulose filter (5) and absorption pad (6) join with the horizontal direction order and are fixed on the described liner (7); And be coated with the colored latex particle of tape label on the described fiberglass packing (2); Be provided with the test wire (3) of varicella virus antigen formation and the control line (4) parallel with described test wire on the described nitrocellulose filter (5).
2. varicella IgG antibody test card according to claim 1 is characterized in that, described test wire (3) is positioned between sample pad (1) and the control line (4).
3. varicella IgG antibody test card according to claim 2 is characterized in that, described liner (7) main body is rigid plastic or hard paper.
4. the described varicella IgG antibody test of any one card according to claim 1-3, it is characterized in that, described fiberglass packing (2) is for being coated with the fiberglass packing (2) with the colored latex particle of SPA mark, and described control line (4) is fixed on the upper control line that forms of nitrocellulose filter (5) for SPA.
5. the described varicella IgG antibody test of any one card according to claim 1-3, it is characterized in that, described fiberglass packing (2) is for being coated with the fiberglass packing (2) with the colored latex particle of mouse-anti human IgG labeling of monoclonal antibody, and described control line (4) is fixed on the upper control line (4) that forms of nitrocellulose filter (5) for sheep anti-mouse igg antibody.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220591909 CN202854143U (en) | 2012-11-09 | 2012-11-09 | Detection card for varicella IgG (Intravenous Gamma Globulin) antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220591909 CN202854143U (en) | 2012-11-09 | 2012-11-09 | Detection card for varicella IgG (Intravenous Gamma Globulin) antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202854143U true CN202854143U (en) | 2013-04-03 |
Family
ID=47985326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201220591909 Expired - Lifetime CN202854143U (en) | 2012-11-09 | 2012-11-09 | Detection card for varicella IgG (Intravenous Gamma Globulin) antibody |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202854143U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109991416A (en) * | 2019-03-12 | 2019-07-09 | 江苏伯纳德生物科技发展有限公司 | A kind of immunochromatographyassay assay reagent box and preparation method thereof |
-
2012
- 2012-11-09 CN CN 201220591909 patent/CN202854143U/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109991416A (en) * | 2019-03-12 | 2019-07-09 | 江苏伯纳德生物科技发展有限公司 | A kind of immunochromatographyassay assay reagent box and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104007261B (en) | Fowl three kinds of breathing problem three quick detection kit and application | |
| CN102830229B (en) | Detection reagent of treponema pallidum IgM (Immunoglobulin M) antigen colloidal gold method and preparation method thereof | |
| CN103983776A (en) | Colloidal gold immunochromatography test strip for simultaneously detecting viral antigens and antibodies | |
| CN102087294B (en) | Immunochromatographic test strip for rapidly detecting malaria and preparation method thereof | |
| CN105859843A (en) | Preparation method of respiratory syncytial virus antigen and rapid respiratory syncytial virus antibody detection kit prepared from antigen | |
| CN111458505A (en) | Detection paper and method for simultaneously and quantitatively detecting IgG and IgM contents of new coronavirus | |
| CN115176162A (en) | Novel coronavirus antigen and detection use thereof | |
| CN105753981B (en) | The immune chromatography reagent kit of anti-human Respiratory Syncytial Virus(RSV) N protein antibody and the application antibody | |
| CN202854142U (en) | Pertussis IgG antibody test card | |
| CN101887061A (en) | Colloidal gold immuno-chromatography test paper strip used for detecting escherichia coil F5 pilus and preparation method thereof | |
| CN101936997A (en) | Human anti-rabies virus IgG antibody ELISA test kit | |
| CN202854143U (en) | Detection card for varicella IgG (Intravenous Gamma Globulin) antibody | |
| CN202854144U (en) | Detection card for parotitis IgG (Intravenous Gamma Globulin) antibody | |
| CN202854145U (en) | Joint detection card for measles, parotitis and rubella IgG (Intravenous Gamma Globulin) antibodies | |
| CN106636004A (en) | TMV-CMV-PVY three-virus (tobacco mosaic virus, cucumber mosaic virus and potato virus) colloidal gold rapid test strip | |
| CN103134927A (en) | Method used for detecting shigella and reagent box | |
| CN202854150U (en) | Poliovirus II type IgG antibody test card | |
| KR101587645B1 (en) | Multi-influenza Detection Kit and Method for Detecting Influenza Using the Same | |
| CN103399154A (en) | Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper | |
| CN101936998A (en) | Antirabies virus IgG (Immunoglobulin G) antibody ELISA (Enzyme Linked Immunosorbent Assay) detection kit for dogs | |
| CN105974111B (en) | A kind of method of rheumatoid factor (IgM type) and other antigen-specific IgM antibody joint-detections | |
| CN104931685A (en) | Luminescence immune detection method based on recombinant antigen carrying His tag | |
| CN202870096U (en) | Detection card for IgG (Intravenous Gamma Globulin) antibody of III-form poliovirus | |
| CN202182882U (en) | Cytomegalovirus IgM and IgG antibody associated detecting test paper | |
| CN203811607U (en) | Hepatitis B virus and b type haemophilus influenzae IgG (Intravenous Gamma Globulin) antibody joint detection card |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20130403 |
|
| CX01 | Expiry of patent term |